Jodie Fleming to Cell Line, Tumor
This is a "connection" page, showing publications Jodie Fleming has written about Cell Line, Tumor.
Connection Strength
0.547
-
Barrow MA, Martin ME, Coffey A, Andrews PL, Jones GS, Reaves DK, Parker JS, Troester MA, Fleming JM. A functional role for the cancer disparity-linked genes, CRY?B2 and CRY?B2P1, in the promotion of breast cancer. Breast Cancer Res. 2019 09 11; 21(1):105.
Score: 0.108
-
Martin ME, Reaves DK, Jeffcoat B, Enders JR, Costantini LM, Yeyeodu ST, Botta D, Kavanagh TJ, Fleming JM. Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-?1 secretion. Nanomedicine. 2019 10; 21:102070.
Score: 0.107
-
Fleming JM, Yeyeodu ST, McLaughlin A, Schuman D, Taylor DK. In Situ Drug Delivery to Breast Cancer-Associated Extracellular Matrix. ACS Chem Biol. 2018 10 19; 13(10):2825-2840.
Score: 0.101
-
Reaves DK, Fagan-Solis KD, Dunphy K, Oliver SD, Scott DW, Fleming JM. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. PLoS One. 2014; 9(3):e91747.
Score: 0.074
-
Fleming JM, Ginsburg E, McAndrew CW, Heger CD, Cheston L, Rodriguez-Canales J, Vonderhaar BK, Goldsmith P. Characterization of ?7/11, a functional prolactin-binding protein. J Mol Endocrinol. 2013 Feb; 50(1):79-90.
Score: 0.068
-
Fleming JM, Ginsburg E, Oliver SD, Goldsmith P, Vonderhaar BK. Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer. BMC Cancer. 2012 Jun 22; 12:266.
Score: 0.065
-
Oladapo HO, Tarpley M, Sauer SJ, Addo KA, Ingram SM, Strepay D, Ehe BK, Chdid L, Trinkler M, Roques JR, Darr DB, Fleming JM, Devi GR, Williams KP. Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in?vivo tumor growth of inflammatory breast cancer cells. Cancer Lett. 2017 12 28; 411:136-149.
Score: 0.024